BACKGROUND: Heterotaxy syndrome is caused by left-right asymmetry disturbances and is associated with abnormal lateralisation of the abdominal and thoracic organs. The heart is frequently involved and the severity of the abnormality usually determines the outcome. METHODS: We performed a direct sequence analysis of the coding sequence of genes including Zinc Finger Protein of the Cerebellum 3, Left-Right Determination Factor 2, Activin A Receptor Type IIB, and Cryptic in 47 patients with laterality defects and congenital cardiac disease. RESULTS: Of the 47 patients, 31 (66%) had atrioventricular septal defects, 34 (72%) had abnormal systemic venous return, 25 (53%) had transposed or malposed great arteries, and 20 (43%) had pulmonary venous abnormalities. We identified two novel genetic changes in Zinc Finger Protein of the Cerebellum 3, and these variants were not present in 100 ethnically matched control samples. One previously reported missense mutation in Activin A Receptor Type IIB was identified in two unrelated subjects. The genetic changes identified in this study are all located in conserved regions and are predicted to affect protein function in left-right axis formation and cardiovascular development. CONCLUSIONS: Mutations in Zinc Finger Protein of the Cerebellum 3 and Activin A Receptor Type IIB were identified in 4 of the 47 patients with heterotaxy syndrome for a yield of approximately 8.5%. Our results expand the mutation spectrum of monogenic heterotaxy syndrome with associated cardiac anomalies and suggest that there are other causes of heterotaxy yet to be identified.
BACKGROUND:Heterotaxy syndrome is caused by left-right asymmetry disturbances and is associated with abnormal lateralisation of the abdominal and thoracic organs. The heart is frequently involved and the severity of the abnormality usually determines the outcome. METHODS: We performed a direct sequence analysis of the coding sequence of genes including Zinc Finger Protein of the Cerebellum 3, Left-Right Determination Factor 2, Activin A Receptor Type IIB, and Cryptic in 47 patients with laterality defects and congenital cardiac disease. RESULTS: Of the 47 patients, 31 (66%) had atrioventricular septal defects, 34 (72%) had abnormal systemic venous return, 25 (53%) had transposed or malposed great arteries, and 20 (43%) had pulmonary venous abnormalities. We identified two novel genetic changes in Zinc Finger Protein of the Cerebellum 3, and these variants were not present in 100 ethnically matched control samples. One previously reported missense mutation in Activin A Receptor Type IIB was identified in two unrelated subjects. The genetic changes identified in this study are all located in conserved regions and are predicted to affect protein function in left-right axis formation and cardiovascular development. CONCLUSIONS: Mutations in Zinc Finger Protein of the Cerebellum 3 and Activin A Receptor Type IIB were identified in 4 of the 47 patients with heterotaxy syndrome for a yield of approximately 8.5%. Our results expand the mutation spectrum of monogenic heterotaxy syndrome with associated cardiac anomalies and suggest that there are other causes of heterotaxy yet to be identified.
Authors: U Gaio; A Schweickert; A Fischer; A N Garratt; T Müller; C Ozcelik; W Lankes; M Strehle; S Britsch; M Blum; C Birchmeier Journal: Curr Biol Date: 1999-11-18 Impact factor: 10.834
Authors: Elizabeth Goldmuntz; Richard Bamford; Jayaprakash D Karkera; June dela Cruz; Erich Roessler; Maximilian Muenke Journal: Am J Hum Genet Date: 2002-01-17 Impact factor: 11.025
Authors: A Mégarbané; N Salem; E Stephan; R Ashoush; D Lenoir; V Delague; R Kassab; J Loiselet; P Bouvagnet Journal: Eur J Hum Genet Date: 2000-09 Impact factor: 4.246
Authors: R N Bamford; E Roessler; R D Burdine; U Saplakoğlu; J dela Cruz; M Splitt; J A Goodship; J Towbin; P Bowers; G B Ferrero; B Marino; A F Schier; M M Shen; M Muenke; B Casey Journal: Nat Genet Date: 2000-11 Impact factor: 38.330
Authors: C Meno; J Takeuchi; R Sakuma; K Koshiba-Takeuchi; S Ohishi; Y Saijoh; J Miyazaki; P ten Dijke; T Ogura; H Hamada Journal: Dev Cell Date: 2001-07 Impact factor: 12.270
Authors: Erich Roessler; Wuhong Pei; Maia V Ouspenskaia; Jayaprakash D Karkera; Jorge Ivan Veléz; Sharmilla Banerjee-Basu; Gretchen Gibney; Philip J Lupo; Laura E Mitchell; Jeffrey A Towbin; Peter Bowers; John W Belmont; Elizabeth Goldmuntz; Andreas D Baxevanis; Benjamin Feldman; Maximilian Muenke Journal: Mol Genet Metab Date: 2009-05-27 Impact factor: 4.797
Authors: Smita M Purandare; Stephanie M Ware; Kin Ming Kwan; Marinella Gebbia; Maria Teresa Bassi; Jian Min Deng; Hannes Vogel; Richard R Behringer; John W Belmont; Brett Casey Journal: Development Date: 2002-05 Impact factor: 6.868
Authors: Aimee D C Paulussen; Anja Steyls; Jo Vanoevelen; Florence Hj van Tienen; Ingrid P C Krapels; Godelieve Rf Claes; Sonja Chocron; Crool Velter; Gita M Tan-Sindhunata; Catarina Lundin; Irene Valenzuela; Balint Nagy; Iben Bache; Lisa Leth Maroun; Kristiina Avela; Han G Brunner; Hubert J M Smeets; Jeroen Bakkers; Arthur van den Wijngaard Journal: Eur J Hum Genet Date: 2016-07-13 Impact factor: 4.246
Authors: Fernando Cristo; José M Inácio; Salomé de Almeida; Patrícia Mendes; Duarte Saraiva Martins; José Maio; Rui Anjos; José A Belo Journal: BMC Med Genet Date: 2017-07-24 Impact factor: 2.103